ABL (P210) mRNA levels detected by dPCR and qPCR methods in patients with chronic myeloid leukemia
ABL (P210) mRNA expression in patients with chronic myeloid leukemia (CML) . Methods: In this non-interventional, cross-sectional study, BCR::ABL (P210) mRNA was simultaneously measured by dPCR and qPCR in peripheral blood samples collected from patients with CML who underwent tyrosine kinase inhibitor therapy and who achieved at least a complete cytogenetic response from September 2021 to February 2023 at Peking University People's Hospital. The difference, correlation, and agreement between the two methods were evaluated using the Wilcoxon signed-rank test, Spearman's correlation, and Bland-Altman analysis, respectively. Results: In total, 459 data pairs for BCR::ABL mRNA expression measured by dPCR and qPCR from 356 patients with CML were analyzed. There was a significant difference in BCR::ABL mRNA expression between the two methods (P<0.001). When analyzed by the depth of the molecular response (MR), a significant difference only existed for patients with ≥MR4.5 (P<0.001). No significant difference was observed for those who did not achieve a major MR (no MMR; P=0.922) or for those who achieved a major MR (MMR; P=0.723) or MR4 (P=0.099). There was a moderate correlation between the BCR::ABL mRNA expression between the two methods (r=0.761, P<0.001). However, the correlation gradually weakened or disappeared as the depth of the MR increased (no MMR: r=0.929, P<0.001; MMR: r=0.815, P<0.001; MR4: r=0.408, P<0.001; MR4.5: r=0.176, P=0.176). In addition, the agreement in BCR::ABL mRNA expression between the two methods in those with MR4.5 was weaker than other groups (no MMR: ▉= 0.042, P=0.846; MMR:▉=0.054, P=0.229; MR4:▉=-0.020, P=0.399; MR4.5:▉=-0.219, P<0.001) . Conclusions: dPCR is more accurate than qPCR for measuring BCR::ABL (P210) mRNA expression in patients with CML who achieve a stable deep MR.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
---|---|
Enthalten in: |
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi - 44(2023), 11 vom: 14. Nov., Seite 906-910 |
Sprache: |
Chinesisch |
---|
Beteiligte Personen: |
Gao, H L [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 12.01.2024 Date Revised 12.01.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.3760/cma.j.issn.0253-2727.2023.11.004 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM366761390 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM366761390 | ||
003 | DE-627 | ||
005 | 20240114234405.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240114s2023 xx |||||o 00| ||chi c | ||
024 | 7 | |a 10.3760/cma.j.issn.0253-2727.2023.11.004 |2 doi | |
028 | 5 | 2 | |a pubmed24n1257.xml |
035 | |a (DE-627)NLM366761390 | ||
035 | |a (NLM)38185519 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a chi | ||
100 | 1 | |a Gao, H L |e verfasserin |4 aut | |
245 | 1 | 0 | |a Comparison of BCR::ABL (P210) mRNA levels detected by dPCR and qPCR methods in patients with chronic myeloid leukemia |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 12.01.2024 | ||
500 | |a Date Revised 12.01.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Objective: To compare digital polymerase chain reaction (dPCR) and real-time quantitative PCR (qPCR) measurements of BCR::ABL (P210) mRNA expression in patients with chronic myeloid leukemia (CML) . Methods: In this non-interventional, cross-sectional study, BCR::ABL (P210) mRNA was simultaneously measured by dPCR and qPCR in peripheral blood samples collected from patients with CML who underwent tyrosine kinase inhibitor therapy and who achieved at least a complete cytogenetic response from September 2021 to February 2023 at Peking University People's Hospital. The difference, correlation, and agreement between the two methods were evaluated using the Wilcoxon signed-rank test, Spearman's correlation, and Bland-Altman analysis, respectively. Results: In total, 459 data pairs for BCR::ABL mRNA expression measured by dPCR and qPCR from 356 patients with CML were analyzed. There was a significant difference in BCR::ABL mRNA expression between the two methods (P<0.001). When analyzed by the depth of the molecular response (MR), a significant difference only existed for patients with ≥MR4.5 (P<0.001). No significant difference was observed for those who did not achieve a major MR (no MMR; P=0.922) or for those who achieved a major MR (MMR; P=0.723) or MR4 (P=0.099). There was a moderate correlation between the BCR::ABL mRNA expression between the two methods (r=0.761, P<0.001). However, the correlation gradually weakened or disappeared as the depth of the MR increased (no MMR: r=0.929, P<0.001; MMR: r=0.815, P<0.001; MR4: r=0.408, P<0.001; MR4.5: r=0.176, P=0.176). In addition, the agreement in BCR::ABL mRNA expression between the two methods in those with MR4.5 was weaker than other groups (no MMR: ▉= 0.042, P=0.846; MMR:▉=0.054, P=0.229; MR4:▉=-0.020, P=0.399; MR4.5:▉=-0.219, P<0.001) . Conclusions: dPCR is more accurate than qPCR for measuring BCR::ABL (P210) mRNA expression in patients with CML who achieve a stable deep MR | ||
650 | 4 | |a Comparative Study | |
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Digital polymerase chain reaction | |
650 | 4 | |a Fusion proteins, BCR::ABL | |
650 | 4 | |a Leukemia, myeloid, chronic | |
650 | 4 | |a Real-time quantitative polymerase chain reaction | |
650 | 7 | |a RNA, Messenger |2 NLM | |
700 | 1 | |a Hao, Y |e verfasserin |4 aut | |
700 | 1 | |a Chen, W M |e verfasserin |4 aut | |
700 | 1 | |a Li, L D |e verfasserin |4 aut | |
700 | 1 | |a Wang, X |e verfasserin |4 aut | |
700 | 1 | |a Qin, Y Z |e verfasserin |4 aut | |
700 | 1 | |a Jiang, Q |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi |d 1993 |g 44(2023), 11 vom: 14. Nov., Seite 906-910 |w (DE-627)NLM081873417 |x 0253-2727 |7 nnns |
773 | 1 | 8 | |g volume:44 |g year:2023 |g number:11 |g day:14 |g month:11 |g pages:906-910 |
856 | 4 | 0 | |u http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.11.004 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 44 |j 2023 |e 11 |b 14 |c 11 |h 906-910 |